Chest
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: There is limited knowledge related to the prevalence and determinants of chronic bronchitis (CB) among Canadian First Nations people. The aim of the current study was to determine the prevalence of CB and associated risk factors among First Nations People. ⋯ The following authors have nothing to disclose: Punam Pahwa, Chandima Karunanayake, Donna Rennie, Kathleen McMullin, Josh Lawson, Jeremy Seeseequasis, Arnold Naytowhow, Akwasi Owusu-Kyem, Louise Hagel, Sylvia Abonyi, Jo-Ann Episkenew, James DosmanNo Product/Research Disclosure Information.
-
Critical Care Posters ISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Cardiac arrest patients are often admitted to CCU/MICU depending on academic setting. We aimed to compare outcomes of cardiac arrest patients based on demographics of the patients admitted to CCU Vs MICU. We also tried to identify role of hypothermia in different type underlying arrest rhythms ⋯ Patients admitted to CCU had better survival rate, home returning rate, less LOS and Ventilator dependent day. The majority of the patients admitted to CCU had Vfib as underlying rhythm compared to PEA/Asystole in MICU patients. Greatest benefit of therapeutic hypothermia was seen in patients with Vfib than PEA/Asystole, with inverse survival relationship noticed if presenting rhythm was asystole.Reference #1: Circulation. 2003; 108: 118-121DISCLOSURE: The following authors have nothing to disclose: Parth Rali, Win NaingNo Product/Research Disclosure Information.
-
Slide PresentationPRESENTED ON: Monday, March 24, 2014 at 10:45 AM - 11:45 AMPURPOSE: The purpose of this study was to determine if any program or factor produces a different and more effective result in increasing smoking cessation rates in an outpatient clinic ⋯ The following authors have nothing to disclose: Can Ozturk, Alev Kararli BingulNo Product/Research Disclosure Information.
-
Cancer Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Cisplatin, is a heavy metal complex which is used alone or with other cytotoxics,for long years in the treatment of solid tumors. Although renal and gastrointestinal toxicity are commonly dose limiting, several neurological complications have been described,particularly after high doses. The main neurological side effects are peripheral sensory neuropathy predominantly and ototoxicity, which may be irreversible. Seizures are rare and are often reversible. ⋯ We conclude that physicians using cisplatin chemotherapy should be aware of this rare complication.Reference #1: Steeghs, N.a c; de Jongh, F. E.a d; Smitt, P. A. E. Sillevisb; Bent, M. J. van denb .Cisplatin-induced encephalopathy and seizures. Anti-Cancer Drugs. 2003 - Volume 14 - Issue 6 - pp 443-446 Case ReportReference #2: Fuse-Nagase Y, Suwa K, Nagao Y.Partial seizures associated with cisplatin administration: a case report.Clin Electroencephalogr. 1997 Jan;28(1):55-6DISCLOSURE: The following authors have nothing to disclose: Makbule Ozlem Akbay, Dilek Ernam, Nuray Erdal, Aysegul CubukNo Product/Research Disclosure Information.
-
Physiology/PFTs/Rehabilitation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: The purpose of this study was to establish a reliable method for the assessment of the diaphragmatic motion via the M-mode ultrasound. ⋯ The following authors have nothing to disclose: Filipe Parreira, Rui Machado, Teresa Tomás, Ricardo RibeiroNo Product/Research Disclosure Information.